A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing‐remitting multiple sclerosis

2018 ◽  
Vol 19 ◽  
pp. 50-54 ◽  
Author(s):  
Marcello Moccia ◽  
Raffaele Palladino ◽  
Antonio Carotenuto ◽  
Francesco Saccà ◽  
Cinzia Valeria Russo ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Cohort Study ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Interferon Β ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

scholarly journals Infusion-related events during natalizumab: No need for post-infusion monitoring

2019 ◽  
Vol 26 (12) ◽  
pp. 1590-1593
Author(s):  
Floor C Loonstra ◽  
Johannis A van Rossum ◽  
Zoé LE van Kempen ◽  
Theo Rispens ◽  
Bernard MJ Uitdehaag ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Adverse Event ◽  
Cohort Study ◽  
Adverse Events ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Relapsing Remitting ◽  
Post Infusion ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

This retrospective cohort study assessed the timing of infusion-related adverse events (IAEs) during natalizumab (NTZ) administration in well-documented relapsing-remitting multiple sclerosis (RRMS) patients who had received NTZ infusions in our centre between 2006 and 2018. In 225 RRMS patients (14,174 NTZ infusions), 276 IAEs (1.95%) occurred in 60 patients. All documented severe IAE occurred during infusion. Of the 19 moderate adverse events, 17 were during infusion. None of the reactions that occurred after the infusion required intervention. These results suggest that post-infusion monitoring is not necessary in patients who do not have an adverse event during infusion.

scholarly journals Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

2017 ◽  
Vol 74 (2) ◽  
pp. 219-226 ◽  
Author(s):  
Irene Eriksson ◽  
Thomas Cars ◽  
Fredrik Piehl ◽  
Rickard E. Malmström ◽  
Björn Wettermark ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Cohort Study ◽  
Dimethyl Fumarate ◽  
Population Based ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis
Sign in / Sign up

Export Citation Format

Share Document